Summary
- Current Price
- As of today, MPLT price is $28.75, down -1.81% on
- Current Price All-Time High
- MPLT price is currently -13.61% below its historical high of $33.28 set on
- Market Cap
- MPLT current market cap is $1B, with unknown 1-year change
- PE Ratio
- MPLT PE ratio is unknown
- Revenue
- MPLT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for MPLT is on
Profile
| Metric | Value |
|---|---|
| Full Name | MapLight Therapeutics, Inc. |
| Ticker | NASDAQ: MPLT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | maplightrx.com |
| Employees | 133 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $28.75 | |
| Price, 1D Change | -1.81% | |
| $1B | ||
| - | ||
| - | ||
| 1.37 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.66 | ||
| EPS, 1Y Change | -95.48% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.66 | ||
| EPS Estimate | N/A | -$5.29 |
| EPS Est. Change | N/A | -44.45% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $28.75 | |
| Price Target | - | $35.00 |
| Price Tgt. Change | - | +21.74% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$9.98 | -$3.66 | +63.32% | |
| -$5.29 | N/A | -44.45% | |
| -$4.48 | N/A | -22.33% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $28.75 | |
| $20.15 | ||
| SMA 200 vs Price | -29.92% | |
| $25.53 | ||
| SMA 50 vs Price | -11.22% | |
| 1.37 | ||
| $2.39 | ||
| 52.48 | ||
| 78.90% | ||
| 88.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.66 | ||
| -$578.00K | ||
| - | ||
| -$169.08M | ||
| - | ||
| -$161.15M | ||
| - | ||
| -$168.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 20.01 | ||
| 20.01 | ||
| - | ||
| - | ||
| 35.56 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.26 | ||
| -4.77 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $458.37M | ||
| $305.10M | ||
| $479.51M | ||
| $324.67M | ||
| $21.14M | ||
| $16.23M | ||
| $5.80M | ||
| $891.00K | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $161.15M | ||
| $168.51M | ||
| $578.00K | ||
| $0.00 | ||
| $578.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$138.14M | ||
| -$323.21M | ||
| $469.82M | ||
| $473.00K | ||
| -$138.61M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Craig-Hallum | ||
| HC Wainwright & Co. | ||
| Needham | ||
| TD Cowen | ||
| Canaccord Genuity | ||
| Stifel | ||
| Morgan Stanley | ||
| Leerink Partners | ||
| Jefferies |
Analyst sentiment
Institutional ownership
Screeners with MPLT
FAQ
What is the ticker symbol for MapLight Therapeutics, Inc.?
The ticker symbol for MapLight Therapeutics, Inc. is NASDAQ:MPLT
Does MapLight Therapeutics, Inc. pay dividends?
No, MapLight Therapeutics, Inc. does not pay dividends
What sector is MapLight Therapeutics, Inc. in?
MapLight Therapeutics, Inc. is in the Healthcare sector
What industry is MapLight Therapeutics, Inc. in?
MapLight Therapeutics, Inc. is in the Biotechnology industry
What country is MapLight Therapeutics, Inc. based in?
MapLight Therapeutics, Inc. is headquartered in United States
When did MapLight Therapeutics, Inc. go public?
MapLight Therapeutics, Inc. initial public offering (IPO) was on October 24, 2025
Is MapLight Therapeutics, Inc. in the S&P 500?
No, MapLight Therapeutics, Inc. is not included in the S&P 500 index
Is MapLight Therapeutics, Inc. in the NASDAQ 100?
No, MapLight Therapeutics, Inc. is not included in the NASDAQ 100 index
Is MapLight Therapeutics, Inc. in the Dow Jones?
No, MapLight Therapeutics, Inc. is not included in the Dow Jones index
When was MapLight Therapeutics, Inc. last earnings report?
MapLight Therapeutics, Inc.'s most recent earnings report was on May 14, 2026
When does MapLight Therapeutics, Inc. report earnings?
The next expected earnings date for MapLight Therapeutics, Inc. is August 31, 2026
Data Sources & References
- MPLT Official Website www.maplightrx.com
- MPLT Profile on Yahoo Finance finance.yahoo.com/quote/MPLT
- MPLT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mplt